The effects, per year, upon the UK population of reducing trans fatty acids intake by 1% of daily energy intake across all socio-economic circumstance quintiles.

<p>All figures above are per annum. Totals are rounded.</p><p><i>Numbers of Deaths prevented or postponed (DPP)</i>, <i>life years gained (LYG)</i>, <i>Reductions in Acute Myocardial Infarction (AMI) Admissions</i>, <i>Reductions in Unstable Angina (UA) Admissions and reductions in Heart Failure (HF) admissions</i>. <i>Stratified by gender and socio-economic circumstance (SEC) quintile</i>.</p

The effects, per year, upon the UK population of a reduction from 1% to 0% in trans fatty acids of daily energy intake.

<p>The lower and upper confidence intervals are derived from 5% and 95% centiles of 10,000 Monte Carlo simulations. Since many input variables are not normally distributed the CI may not be symmetrical. All figures above are per annum. Totals are rounded.</p><p><i>Numbers of Deaths prevented or postponed (DPP)</i>, <i>life years gained (LYG)</i>, <i>Reductions in Acute Myocardial Infarction (AMI) Admissions</i>, <i>Reductions in Unstable Angina (UA) Admissions and reductions in Heart Failure (HF) admissions</i>. <i>Stratified by age and gender</i>. <i>Reduction in TFA intake by 0</i>.<i>5% daily energy yield half of the below gains</i>.</p

Life Years Gained (LYGs) per year, with a trans-fats daily energy intake of 0.5% across all socio-economic circumstance (SEC) quintiles modelling unequal intake of trans fatty acids across socio-economic circumstance quintiles.

<p>LYGs by age, gender and socio-economic circumstance. <i>Data source</i>: <i>Hospital Episode Statistics</i>.</p

Deaths prevented or postponed (DPPs) Index with a 1% reduction in daily energy intake of trans fatty acids intake.

<p>DPPs by age, gender and socio-economic circumstance assuming equal TF intake. <i>Data source</i>: <i>Hospital Episode Statistics</i>.</p

The effects, per year, upon the UK population of a reduction from 1% to 0% trans fatty acids of daily energy intake across all socio-economic circumstance quintiles.

<p><i>Numbers of Deaths prevented or postponed (DPP)</i>, <i>life years gained (LYG)</i>, <i>Reductions in Acute Myocardial Infarction (AMI) Admissions</i>, <i>Reductions in Unstable Angina (UA) Admissions and reductions in Heart Failure (HF) admissions</i>. <i>Stratified by gender and socio-economic circumstance (SEC) quintile</i>. <i>0</i>.<i>5% reduction in TFA intake yields half below gains</i>.</p

Hospital Admissions of Acute Myocardial Infarction (AMI), Unstable Angina (UA) and Heart Failure (HF) per year with a 1% reduction in daily energy intake of trans fatty acids intake.

<p>4a Male, 4b Female. Hospital admissions by age. <i>Data source</i>: <i>Hospital Episode Statistics</i>.</p

Life years gained (LYG) per year with a 1% and 0.5% reduction in daily energy intake of trans fatty acids.

<p>Life years gained (LYG) by age and sex. <i>Data source</i>: <i>Hospital Episode Statistics</i>.</p

The effects, per year, upon the UK population of reducing trans fatty acids intake by 1% of daily energy intake across all socio-economic circumstance quintiles.

<p>All figures above are per annum. Totals are rounded.</p><p><i>Numbers of Deaths prevented or postponed (DPP)</i>, <i>life years gained (LYG)</i>, <i>Reductions in Acute Myocardial Infarction (AMI) Admissions</i>, <i>Reductions in Unstable Angina (UA) Admissions and reductions in Heart Failure (HF) admissions</i>. <i>Stratified by gender and socio-economic circumstance (SEC) quintile</i>.</p

Estimated deaths per 100.000 prevented or added in 2040.

<p>Estimated deaths by risk factor change, under three risk factor scenarios.</p

Data on sample characteristics and risk factor values from the Reykjavik study (1981) and REFINE Reykjavik study (2006 and 2010).

<p>Data on sample characteristics and risk factor values from the Reykjavik study (1981) and REFINE Reykjavik study (2006 and 2010).</p